Clinical Trials for Hepatocellular Carcinoma

Find clinical trials for hepatocellular carcinoma. Discover research opportunities and treatment options in your area.

412 Active Trials Found

Showing 412 trials on this page

Page 1 of 21

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

NCT ID: NCT06679985

This clinical trial is studying a new treatment for patients with a specific type of liver cancer called hepatocellular carcinoma (HCC), which is either too advanced or cannot be removed by surgery...

Recruiting

Phase: PHASE2 Type: interventional Locations: Jackson, Mississippi, United States, Duarte, California, United States +20 more

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

NCT ID: NCT06503146

This clinical trial is studying a new imaging method using a special substance called 18F-FAPI-74 to help detect certain types of cancer more effectively. The goal is to find out if this new tracer...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States

STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma

NCT ID: NCT06880523

The STRIDE clinical trial is studying a combination of three medications to see if they can improve treatment outcomes for patients with a type of liver cancer called unresectable hepatocellular ca...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Vancouver, British Columbia, Canada, Calgary, Alberta, Canada

68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)

NCT ID: NCT06852820

This clinical trial is looking at a new treatment for liver cancer, specifically a type called metastatic hepatocellular carcinoma (HCC). The treatment being studied is a drug named 177Lu-PSMA-617,...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Cleveland, Ohio, United States

AHCC® as Immune Modulator in Cancer Patients Treated With Immunotherapy

NCT ID: NCT07118735

This clinical trial is studying whether a natural supplement called AHCC® can help boost the effects of immunotherapy in people with liver cancer, specifically a type called hepatocellular carcinom...

Not yet recruiting

Phase: NA Type: interventional Locations: Tainan, , Taiwan

CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection

NCT ID: NCT05433467

This clinical trial is looking at a new way to locate tiny liver tumors called micro hepatocellular carcinoma before surgery. These tumors are less than 1 centimeter in size and can be tricky to fi...

Recruiting

Phase: NA Type: interventional Locations: Yangzhou, Jiangsu, China

Phase 1, Single-site, Single-arm, Clinical Imaging, and Blood-based Biomarker Trial Utilizing 18F-FSPG PET to Guide Therapy in Hepatocellular Carcinoma

NCT ID: NCT07116486

This clinical trial is studying a new way to help guide treatment for people with hepatocellular carcinoma (HCC), which is a type of liver cancer. The researchers want to see how a special imaging ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

T-Cell Therapy (ECT204) in Adults With Advanced HCC

NCT ID: NCT04864054

This clinical trial is studying a new treatment called ARTEMIS® ECT204 T-cell therapy for adults with advanced liver cancer, specifically a type called hepatocellular carcinoma (HCC). The aim is to...

Recruiting

Phase: PHASE2 Type: interventional Locations: Duarte, California, United States, Westwood, Kansas, United States +5 more

A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC

NCT ID: NCT06294548

This clinical trial is investigating a combination of three medications—valemetostat tosylate (DS-3201b), atezolizumab, and bevacizumab—for patients with advanced hepatocellular carcinoma (HCC), wh...

Recruiting

Phase: PHASE1 Type: interventional Locations: Birmingham, Alabama, United States

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

NCT ID: NCT07118176

This clinical trial is testing a new imaging tracer called 68Ga-FAPi-46 to see how it spreads and collects in the body, especially in cancer and normal tissues. This tracer is used with a special t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

NCT ID: NCT06921785

This clinical trial is studying a new treatment for advanced liver cancer, known as hepatocellular carcinoma (HCC). The researchers want to see if a combination of rilvegostomig and bevacizumab, wi...

Recruiting

Phase: PHASE3 Type: interventional Locations: Barcelona, , Spain, Rochester, Minnesota, United States +106 more

TheraSphere With Durvalumab and Tremelimumab for HCC

NCT ID: NCT05063565

The ROWAN clinical trial is studying a new treatment approach for patients with hepatocellular carcinoma (HCC), which is a type of liver cancer. This trial combines a procedure called TheraSphere, ...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, New Orleans, Louisiana, United States +40 more

CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules

NCT ID: NCT06184152

This clinical trial is studying how well two imaging techniques—contrast-enhanced ultrasound (CEUS) and dynamic contrast-enhanced abbreviated MRI (AMRI)—can detect early-stage liver cancer, known a...

Recruiting

Phase: NA Type: interventional Locations: Ann Arbor, Michigan, United States, Dallas, Texas, United States

Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma

NCT ID: NCT06551272

This clinical trial is investigating whether a special treatment called EXL01, which contains a type of bacteria known as Faecalibacterium prausnitzii, can improve the effectiveness of existing can...

Recruiting

Phase: PHASE2 Type: interventional Locations: Villejuif, , France, Bobigny, , France +4 more

Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma

NCT ID: NCT07110233

This clinical trial is studying a treatment called Yttrium-90 radiation segmentectomy for people with a type of liver cancer called hepatocellular carcinoma (HCC) that cannot be removed by surgery....

Not yet recruiting

Phase: NA Type: interventional Locations: San Francisco, California, United States

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

NCT ID: NCT03228667

The QUILT-3.055 clinical trial is studying new combination treatments for patients with advanced solid tumors, such as lung, kidney, and skin cancers, who have not responded to previous immune ther...

Recruiting

Phase: PHASE2 Type: interventional Locations: Charleston, South Carolina, United States, Buffalo, New York, United States +33 more

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

NCT ID: NCT06887348

This clinical trial is designed to look at the long-term safety of certain treatments called RPx products in patients who have previously received at least one dose of these treatments for conditio...

Not yet recruiting

Type: observational

TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment

NCT ID: NCT07100405

This clinical trial is studying a new treatment approach for people with advanced liver cancer (hepatocellular carcinoma). It looks at how well a combination of two therapies works: TACE, a procedu...

Not yet recruiting

Type: observational Locations: Shanghai, Shanghai, China

Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma

NCT ID: NCT07091942

This clinical trial is studying whether patients with liver cancer (called hepatocellular carcinoma or HCC) who respond partly to a combination medicine (atezolizumab and bevacizumab) and then rece...

Recruiting

Type: observational Locations: Taipei City, Select, Taiwan

A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)

NCT ID: NCT06218511

This clinical trial is studying a new treatment approach for patients with early-stage liver cancer, specifically hepatocellular carcinoma (HCC). Researchers are combining an experimental vaccine (...

Recruiting

Phase: PHASE1 Type: interventional Locations: Napoli, , Italy

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions